| 摘要 |
<p>This invention is directed to a compound wherein R<SUP>1,</SUP> R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP> and L<SUP>1</SUP> are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).</p> |
| 申请人 |
SANOFI-AVENTIS;ALDOUS, SUZANNE, C.;FENNIE, MICHAEL, W.;JIANG, JOHN, Z.;JOHN, STANLY;MU, LAN;PEDGRIFT, BRIAN;PRIBISH, JAMES, R.;RAUCKMAN, BARBARA;SABOL, JEFFREY, S.;STOKLOSA, GRZEGORZ, T.;THURAIRATNAM, SUKANTHINI;VANDEUSEN, CHRISTOPHER, L. |
发明人 |
ALDOUS, SUZANNE, C.;FENNIE, MICHAEL, W.;JIANG, JOHN, Z.;JOHN, STANLY;MU, LAN;PEDGRIFT, BRIAN;PRIBISH, JAMES, R.;RAUCKMAN, BARBARA;SABOL, JEFFREY, S.;STOKLOSA, GRZEGORZ, T.;THURAIRATNAM, SUKANTHINI;VANDEUSEN, CHRISTOPHER, L. |
